HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

45.760

+1.3403.02%

Volume:1.62M

Turnover:73.59M

Market Cap:303.71B

PE:33.11

High:46.160

Open:45.200

Low:44.960

Close:44.420

52wk High:94.869

52wk Low:43.020

Shares:6.64B

HK Float Shares:258.00M

Volume Ratio:2.52

T/O Rate:0.63%

Dividend:0.23

Dividend Rate:0.51%

EPS(LYR):1.382

ROE:12.46%

ROA:7.02%

PB:4.02

PE(LYR):33.11

PS:8.28

Loading ...

Overview Company News Filings

AH Share Premium and Deviation Data for June 29th

Movement Alert｜Hengrui Pharma Rises 3.02% in Regular Trading, Pharma Sector Rallies as Multiple Regulatory Milestones Boost Sentiment

AH Share Premium and Deviation Rankings for June 26

Hengrui Pharma Gets Nod to Trial HRS-4508 Tablets As Advanced Tumor Treatment; Shares Down 4%

MT Newswires Live

Hengrui Pharmaceuticals Unit Wins China Approval to Expand Indication of Cancer Drug

MT Newswires Live

Movement Alert｜Hengrui Pharmaceuticals Falls 3.53% in Regular Trading, Trading at 54.15 HKD

Hengrui Pharmaceuticals Unit Wins China Marketing Approval for Dry Eye Drug

MT Newswires Live

Hengrui Pharma Secures NMPA Approval for Adebrelimab as China’s First Domestic Peri-operative PD-L1 Therapy for Resectable NSCLC

Bulletin Express

Hengrui Pharma secures NMPA green light for China’s first 0.1% water-free cyclosporine eye-drop

Bulletin Express

Hengrui Pharma's Adebrelimab Injection Gains Approval for Additional NSCLC Perioperative Indication

Jiangsu Hengrui Pharmaceuticals - Subsidiary Received Notification from Nmpa Approving New Indication for Adebrelimab Injection

THOMSON REUTERS

AH Share Premium and Deviation Rankings as of June 24th Close

Movement Alert｜Hengrui Medicine Rises 3.47% in Regular Trading, First Self-Developed Innovative Drug Marketing Application Accepted by EMA

Hengrui Pharma Withdraws Registration Application for Emaxitinib Ointment

Hong Kong Stocks Surge: Innovative Drug Sector Rallies on Regulatory Report and New Foreign Investment Policies

European Drug Regulator Accepts Hengrui Pharma's Marketing Application for Revulutamide Tablets

MT Newswires Live

Movement Alert｜Hengrui Medicine Rises 3.73% in Regular Trading, First Self-Developed Innovative Drug Marketing Application Accepted by EMA

Hengrui Pharma's Novel Drug Application for Rezvilutamide Accepted by European Regulator

AH Premium and Deviation Data for June 22

Movement Alert｜Hengrui Medicine Falls 3.02% in Regular Trading, Broad Pharma Sector Sell-Off Amid Geopolitical Headwinds

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/01276/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":45.76,"timestamp":1789698715355,"preClose":44.42,"halted":0,"volume":1615600,"delay":0,"changeRate":0.030166591625393882,"floatShares":258000000,"shares":6637000000,"eps":1.3821066587172084,"marketStatus":"Trading","change":1.34,"latestTime":"09-18 10:32:00","open":45.2,"high":46.16,"low":44.96,"amount":73588936,"amplitude":0.027015,"askPrice":45.88,"askSize":3200,"bidPrice":45.76,"bidSize":3600,"shortable":3,"etf":0,"ttmEps":1.363003133629346,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1789704000000},"marketStatusCode":2,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":44.42,"dividendRate":0.005099,"openAndCloseTimeList":[[1789695000000,1789704000000],[1789707600000,1789718400000]],"volumeRatio":2.520369,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":43.72,"timestamp":1789698717000,"preClose":43.23,"halted":0,"volume":29592600,"delay":0,"premium":"-10.64"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"7.02%","roe":"12.46%","lyrEps":1.382116,"volumeRatio":2.520369,"shares":6637000000,"dividePrice":0.234257,"high":46.16,"amplitude":0.027015,"preClose":44.42,"low":44.96,"week52Low":43.02,"pbRate":"4.02","psRate":"8.28","week52High":94.869,"institutionHeld":0,"latestPrice":45.76,"committee":0.058824,"eps":1.3821159156520646,"divideRate":0.005119,"volume":1615600,"delay":0,"ttmEps":1.3630122626145347,"open":45.2,"prevYearClose":71.002,"prevWeekClose":43.76,"prevMonthClose":46.06,"prevQuarterClose":57.85,"fiveDayClose":43.76,"twentyDayClose":48.2,"sixtyDayClose":56.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-04-29","symbol":"01276","amount":0.22828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"HK","newRecordDate":"2026-04-30","defaultRemindTime":1777426200000,"name":"恒瑞医药","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-27","payableDate":"2026-04-30","currency":"HKD","dateTimestamp":1777392000000,"payDate":"2026-05-27"},{"date":"2026-04-22","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776821400000,"name":null,"time":"","dateTimestamp":1776787200000,"actualEps":null},{"date":"2026-03-26","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761615000000,"name":null,"time":"","dateTimestamp":1761580800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[{"executeDate":"2026-04-29","recordDate":"2026-04-30","paymentDate":"2026-05-27","value":0.22828,"currency":"HKD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.5455,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1786723200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2026-09-17","current":33.572699,"percent":0.012232,"low":36.382401,"twenty":43.78853,"median":51.677537,"eighty":56.979219,"high":65.582363,"avg":51.030206,"sd":7.510525,"marketCap":333185839907.32},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-21","current":52.805265,"twenty":52.880927,"median":57.030538,"eighty":62.209511,"marketCap":431684582485.14},{"date":"2025-11-28","current":55.237621,"twenty":52.99843,"median":56.630614,"eighty":62.069705,"marketCap":453209419829.34},{"date":"2025-12-05","current":54.841023,"twenty":53.00899,"median":56.437545,"eighty":61.965159,"marketCap":450729029423.46},{"date":"2025-12-12","current":56.212257,"twenty":53.045529,"median":56.385682,"eighty":61.891765,"marketCap":462853512587.19},{"date":"2025-12-19","current":54.083493,"twenty":53.045529,"median":56.227363,"eighty":61.831221,"marketCap":446374731108.34},{"date":"2025-12-24","current":54.414957,"twenty":53.090114,"median":56.103073,"eighty":61.798561,"marketCap":450509359276.9},{"date":"2026-01-02","current":53.078544,"twenty":53.065996,"median":55.972407,"eighty":61.785925,"marketCap":441174507319.22},{"date":"2026-01-09","current":56.743223,"twenty":53.0878,"median":56.0944,"eighty":61.695241,"marketCap":472808676524.34},{"date":"2026-01-16","current":55.187351,"twenty":53.304215,"median":56.103073,"eighty":61.405393,"marketCap":461338821289.95},{"date":"2026-01-23","current":52.546341,"twenty":53.0878,"median":56.076447,"eighty":61.296167,"marketCap":438839874056.97},{"date":"2026-01-30","current":51.677141,"twenty":52.994149,"median":55.908509,"eighty":61.278475,"marketCap":433553740508.2},{"date":"2026-02-06","current":50.918226,"twenty":52.680723,"median":55.839154,"eighty":61.101743,"marketCap":428270226283.58},{"date":"2026-02-13","current":51.771686,"twenty":52.512455,"median":55.711415,"eighty":60.890064,"marketCap":437949787160.49},{"date":"2026-02-20","current":51.752043,"twenty":52.351169,"median":55.691374,"eighty":60.824953,"marketCap":437153052005.04},{"date":"2026-02-27","current":50.215456,"twenty":52.151244,"median":55.507566,"eighty":60.720339,"marketCap":428825318404.97},{"date":"2026-03-06","current":49.335298,"twenty":51.80347,"median":55.280584,"eighty":60.654676,"marketCap":417912584744.19},{"date":"2026-03-13","current":48.90444,"twenty":51.75217,"median":55.201025,"eighty":60.572606,"marketCap":416170839186.33},{"date":"2026-03-20","current":48.948437,"twenty":51.671435,"median":55.086674,"eighty":60.515374,"marketCap":414967977646.95},{"date":"2026-03-27","current":47.483832,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"marketCap":414588875872.42},{"date":"2026-04-02","current":49.302243,"twenty":51.107295,"median":54.905743,"eighty":60.227005,"marketCap":432534434303.11},{"date":"2026-04-10","current":49.055344,"twenty":50.995993,"median":54.897923,"eighty":60.186394,"marketCap":433687668394.36},{"date":"2026-04-17","current":48.417764,"twenty":50.589497,"median":54.65026,"eighty":60.143018,"marketCap":428230701835.75},{"date":"2026-04-24","current":45.835792,"twenty":50.342877,"median":54.475147,"eighty":60.015062,"marketCap":426879682872.04},{"date":"2026-04-30","current":44.026312,"twenty":50.285416,"median":54.355253,"eighty":59.903394,"marketCap":410132737659.64},{"date":"2026-05-08","current":43.161515,"twenty":50.207478,"median":54.262074,"eighty":59.804539,"marketCap":403472171949.3},{"date":"2026-05-15","current":44.128138,"twenty":49.985706,"median":54.115335,"eighty":59.70386,"marketCap":413593092820.6},{"date":"2026-05-22","current":41.244553,"twenty":49.583265,"median":53.983854,"eighty":59.631568,"marketCap":385683097978.4},{"date":"2026-05-29","current":40.98659,"twenty":49.34142,"median":53.840414,"eighty":59.564678,"marketCap":384603594259.51},{"date":"2026-06-05","current":38.394132,"twenty":49.063316,"median":53.633194,"eighty":59.459458,"marketCap":360799766229.36},{"date":"2026-06-12","current":39.515262,"twenty":48.81081,"median":53.517715,"eighty":59.36625,"marketCap":371084155232.86},{"date":"2026-06-18","current":39.444808,"twenty":48.417764,"median":53.467699,"eighty":59.301536,"marketCap":371311256576.18},{"date":"2026-06-26","current":39.60241,"twenty":47.951326,"median":53.090114,"eighty":59.187086,"marketCap":370974287810.31},{"date":"2026-07-03","current":44.319925,"twenty":47.638943,"median":53.015805,"eighty":59.069259,"marketCap":415476044901.86},{"date":"2026-07-10","current":45.319748,"twenty":47.348429,"median":52.993744,"eighty":59.024871,"marketCap":424327469311.14},{"date":"2026-07-17","current":43.189222,"twenty":46.151454,"median":52.805265,"eighty":58.96135,"marketCap":405818502739.33},{"date":"2026-07-24","current":43.433009,"twenty":45.632553,"median":52.604835,"eighty":58.912251,"marketCap":408200902707.63},{"date":"2026-07-31","current":43.935338,"twenty":45.29749,"median":52.543618,"eighty":58.877468,"marketCap":413706414238.87},{"date":"2026-08-07","current":44.394532,"twenty":45.008473,"median":52.339287,"eighty":58.813302,"marketCap":418841988303.56},{"date":"2026-08-14","current":42.6704,"twenty":44.628794,"median":52.189578,"eighty":58.452058,"marketCap":403085247281.44},{"date":"2026-08-21","current":40.686911,"twenty":44.408765,"median":52.120101,"eighty":57.75211,"marketCap":366558497066.13},{"date":"2026-08-28","current":40.334802,"twenty":44.24321,"median":51.814807,"eighty":57.336246,"marketCap":363468645736.13},{"date":"2026-09-04","current":39.220129,"twenty":44.050964,"median":51.771686,"eighty":57.152374,"marketCap":353565883607.49},{"date":"2026-09-11","current":36.382401,"twenty":43.912617,"median":51.717719,"eighty":57.022157,"marketCap":328426636361.34},{"date":"2026-09-17","current":36.861452,"twenty":43.78853,"median":51.677537,"eighty":56.979219,"marketCap":333185839907.32}],"updateTime":1789698720058},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1156215187","title":"AH Share Premium and Deviation Data for June 29th","url":"https://stock-news.laohu8.com/highlight/detail?id=1156215187","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156215187?lang=en_us&edition=fundamental","pubTime":"2026-06-29 16:24","pubTimestamp":1782721495,"startTime":"0","endTime":"0","summary":"Data as of the market close on June 29th shows NE ELECTRIC (HKG: 00042), ZHEJIANG SHIBAO (HKG: 01057), and SINOPEC SSC (HKG: 01033) had the highest AH share premium rates at 864.29%, 372.60%, and...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU0314109678.HKD","LU0441854154.USD","LU0531971595.HKD","LU0211977185.USD","LU0082770016.SGD","LU0072462343.USD","LU1769817096.USD","LU1282651121.HKD","LU0456827905.SGD","LU0049853897.USD","LU0029875118.USD","LU0868486357.SGD","IE00B29SXG58.USD","LU1328277881.USD","LU1152091168.USD","BK1604","BK1535","LU0072913022.USD","BK1110","LU0878004406.USD","LU0516422952.EUR","LU1282649810.SGD","BK1198","LU0106252389.USD","LU1831875114.USD","LU0315179316.USD","BK1562","LU0348783662.USD","BK1554","SG9999002828.SGD","LU0607220059.USD","LU0164872284.USD","HK0000500386.USD","BK1202","IE00BF5LJ272.USD","LU0540923850.HKD","IE0034224299.USD","LU1880383440.USD","SG9999002463.SGD","LU0650527681.SGD","03200","LU0630378429.USD","BK1523","LU1515016050.SGD","02208","IE0003895053.USD","LU2476274720.SGD","IE00BGHQDM52.EUR","BK1552","LU1642822792.SGD","LU0640798160.USD","BK1560","LU1251922891.USD","BK1592","LU2294711473.HKD","LU0469268626.HKD","LU0605514214.HKD","LU0543330566.HKD","HK0000151867.HKD","159982","LU1366334578.USD","LU0149534421.HKD","BK1147","BK1231","LU0737861699.HKD","LU0831093199.SGD","02218","LU0359201885.HKD","HK0000252160.HKD","BK1505","LU0328353924.USD","LU0762540952.USD","LU0865486749.SGD","01108","LU0011963245.USD","LU2008162690.USD","02691","SG9999011746.SGD","LU1770034418.SGD","LU0348766576.USD","LU1303224171.USD","SG9999000459.SGD","IE00BZ08YR35.GBP","LU2242644610.SGD","LU0348825331.USD","LU0235996351.USD","LU2399975544.HKD","LU0819123356.HKD","LU1808992512.USD","BK1537","LU0061477393.USD","LU2097828557.USD","LU0244354667.USD","LU0828237940.HKD","LU0266512473.USD","LU0287142896.SGD","LU0051755006.USD","03145","00168","LU0254981946.USD","LU0589944569.HKD","IE00BYV24P56.USD","SG9999002562.SGD","IE00BVYPNQ40.USD","LU0831103253.SGD","LU0048580855.USD","LU0348788117.USD","LU2348774022.SGD","BK1546","BK1550","LU0181495838.USD","HPAD.SI","LU1813983027.USD","LU0149721374.USD","BK1141","IE00BVYPNP33.GBP","01330","LU0648948544.HKD","LU1105468828.SGD","LU0797268264.HKD","LU0593848301.USD","LU2097828805.USD","LU0456846285.SGD","LU2045819591.USD","HK0000286598.CNH","IE00B0169L03.USD","LU0898667661.SGD","LU0672654166.SGD","LU0320764755.SGD","LU0039217434.USD","BK1205","IE00BMCWC346.EUR","LU0588545490.SGD","BK1173","LU1282651048.USD","LU1044875133.USD","LU0651947912.USD","LU0165289439.USD","LU1988902786.USD","LU0384037296.USD","LU1152091754.HKD","LU1820825898.SGD","LU0140636845.USD","BK1558","LU0620787316.HKD","02899","LU2778985437.USD","LU0117844026.USD","LU0307460666.USD","LU0882747503.HKD","LU0320764599.SGD","LU0210527791.USD","LU0588546209.SGD","01276","LU1224709979.USD","IE0008369823.USD","LU0449515922.USD","LU0231483743.USD","82318","LU1046422090.SGD","601318","LU0918141887.USD","LU0348784397.USD","HK0000306685.HKD","LU0531970944.HKD","IE00BGV7N243.SGD","BK1578","LU1769817179.HKD","LU0819121731.USD","BK1193","LU0594300179.USD","01081","LU0463099449.HKD","LU1242518857.USD","IE00B5MMRT66.SGD","06066","LU1044874839.SGD","LU0117841782.USD","03661","BK1144","LU0880133367.SGD","LU1282648689.USD","LU0348735423.USD","LU0348827113.USD","LU1880383366.USD","BK1544","LU0054450605.USD","BK1510","LU0488056044.USD","LU0128522157.USD","IE00B3M56506.USD","02318","LU2476274308.USD","LU0634319403.HKD","BK1183","LU0979878070.USD","LU0096374516.USD","LU0516422440.USD","LU0329678170.USD","LU0862451837.USD","LU1235295612.USD","LU0871576103.HKD","HK0000306701.USD","00300","LU1048588211.SGD","LU1048596156.SGD","LU0455707207.USD","03986","IE0008368742.USD","LU0588545904.SGD","EWH","03750","LU0784639295.USD","LU0611395673.USD","LU0196878994.USD","LU1188198961.HKD","LU1504937902.USD","00042","LU0210526637.USD","LU0106959298.USD","LU1064131342.USD","HK0000352382.USD","LU0501845795.SGD","LU0315178854.USD","LU1224444064.USD","LU0327786744.USD","LU0082770016.USD","BK1583","LU1720050803.USD","BK1105","LU0052750758.USD","BK1521","LU0043850808.USD","LU0228367735.SGD","LU0348816934.USD","LU1655091459.SGD","LU2097828631.EUR","LU0828237510.HKD","LU0572944931.SGD","LU0329678337.USD","BK1507","LU0630378692.HKD","00187","LU0823426308.USD","03296","PAImain","LU1023057109.AUD","BK1506","LU0345780281.USD","BK1526","00553","LU1211504680.USD","SG9999001903.USD","HK0000320223.HKD","IE00BZ08YS42.EUR","LU1226287529.USD","LU2543165471.USD","BK1140","HK0000352291.HKD","LU0762541174.USD","LU2348773727.SGD","IE00B031J352.USD","LU0164939612.USD","LU0588545730.USD","LU1244550221.USD","LU0449509016.USD","LU1366334651.USD","LU1051769294.HKD","LU0417516902.SGD","LU2153591404.USD","LU0456854461.SGD","BK1513","LU2097828474.EUR","LU0214875030.USD","LU0918141705.HKD","BK1184","00916","01349","SG9999014674.SGD","LU0348805143.USD","LU0348767384.USD","LU0708995583.HKD","LU3063872942.SGD","LU0516423091.SGD","03678","LU0737861772.HKD","LU1993786604.SGD","BK1576","LU1051768304.USD","IE00BZ08YT58.USD","LU1008478684.HKD","LU2152927971.USD","LU0084288322.USD","BK1594","LU1115378108.SGD","LU0348814723.USD","LU0651946864.USD","PNGAY","LU0862451753.SGD","LU0823426480.USD","399300","SG9999006597.SGD","LU2424517915.HKD","02338","LU0675040207.SGD","LU1807302812.USD","02465","03369","BK1235","LU0370786039.SGD","LU0359202008.SGD","LU2039709279.SGD","LU1282649141.HKD","00895","LU0890818403.SGD","LU0886674414.USD","LU2264538146.SGD","IE00B031HY20.USD","LU0516423174.USD","03866","LU0417516738.SGD","LU0821914370.USD","LU1960683339.HKD","IE0031814852.USD","LU2177674079.SGD","LU0516422366.SGD","BK1154","HK0001040168.HKD","01057","LU0359201612.USD","LU1688375341.USD","LU0762542818.HKD","LU1961090484.USD","LU1675838814.USD","LU1282649067.USD","LU0266512127.USD","LU0417516571.SGD","LU0173614495.USD","LU1171460220.USD","LU0561508036.HKD","LU0791591158.USD","LU1244550577.SGD","BK1116","LU0049112450.USD","HK0001040143.USD","LU0164865239.USD","BK1237","LU0229945570.USD","IE0032431581.USD","LU1146622755.USD","LU2279858448.HKD","LU0197773673.USD","LU2226246903.HKD","BK1171","LU0823040885.USD","LU0197773160.USD","03143","LU0293314216.USD","HK0000320264.USD","LU0878005551.USD","LU1481107354.HKD","LU2293587155.HKD","LU1981816686.USD","BK1564","LU1044876610.USD","LU0163747925.USD","LU0164880469.USD","03968","02359","LU0594300419.USD","LU1244550494.USD","LU0345780521.USD","LU2153592121.USD","LU0856984785.SGD","HK0000252152.HKD","BK1180","BK1149","LU0431992006.USD","BK1163","BK1610","IE00B543WZ88.USD","LU0326950275.SGD","LU0791590937.USD","01033","LU0348783233.USD","LU0543330483.HKD","BK1214","SG9999004220.SGD","BK1522","06869","LU0502904849.HKD","LU1242518931.SGD","LU2125910500.SGD","LU0067412154.USD","LU1719994722.HKD","LU2097828714.EUR","LU0228659784.USD","LU1794554557.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157085512","title":"Movement Alert｜Hengrui Pharma Rises 3.02% in Regular Trading, Pharma Sector Rallies as Multiple Regulatory Milestones Boost Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1157085512","media":"Market Focus","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157085512?lang=en_us&edition=fundamental","pubTime":"2026-06-29 10:09","pubTimestamp":1782698980,"startTime":"0","endTime":"0","summary":"On June 29, Hengrui Pharma rose 3.02% in regular trading, trading at HKD 55.55/share, with turnover of HKD 109 million. The stock rebounded from a 6.45% decline in the prior session, supported by a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178163155","title":"AH Share Premium and Deviation Rankings for June 26","url":"https://stock-news.laohu8.com/highlight/detail?id=1178163155","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178163155?lang=en_us&edition=fundamental","pubTime":"2026-06-26 16:24","pubTimestamp":1782462278,"startTime":"0","endTime":"0","summary":"The trading session on June 26 concluded with data revealing the top and bottom three stocks in terms of AH share premium rates and deviation values. The highest AH premium rates were recorded by NE...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0164880469.USD","BK1202","01330","LU2039709279.SGD","00916","LU0828237510.HKD","LU2097828805.USD","LU0348788117.USD","LU1366334578.USD","00588","IE0008369823.USD","02208","LU0516422952.EUR","LU1224709979.USD","LU0501845795.SGD","LU2177674079.SGD","IE00BZ08YR35.GBP","01688","LU0287142896.SGD","LU0463099449.HKD","LU0589944569.HKD","IE00BMCWC346.EUR","LU0314109678.HKD","LU0431992006.USD","BK1558","LU0540923850.HKD","IE00BVYPNP33.GBP","01081","LU0345780281.USD","LU0348766576.USD","IE00BZ08YS42.EUR","LU0561508036.HKD","LU0672654166.SGD","LU0449515922.USD","LU0417516738.SGD","09989","BK1140","LU0572944931.SGD","IE00BYV24P56.USD","LU1880383366.USD","LU1282649810.SGD","02338","LU2125910500.SGD","LU1831875114.USD","BK1583","SG9999004220.SGD","BK1149","BK1546","LU2543165471.USD","HK0000500386.USD","LU0979878070.USD","LU0620787316.HKD","LU1188198961.HKD","LU0543330566.HKD","LU1675838814.USD","LU1720050803.USD","LU0823040885.USD","LU0149534421.HKD","LU0052750758.USD","LU0149721374.USD","BK1110","LU2045819591.USD","02899","HK0001040168.HKD","LU0370786039.SGD","LU0640798160.USD","IE00B3M56506.USD","LU0266512127.USD","BK1141","LU0871576103.HKD","LU1242518931.SGD","LU0449509016.USD","LU1282649141.HKD","LU0320764599.SGD","LU0043850808.USD","LU0918141887.USD","LU0039217434.USD","LU2097828474.EUR","LU0516422440.USD","LU0228367735.SGD","LU1244550577.SGD","SG9999006597.SGD","IE00BVYPNQ40.USD","BK1537","LU1807302812.USD","LU0516422366.SGD","BK1576","IE00B031J352.USD","LU0791591158.USD","LU0244354667.USD","LU0327786744.USD","BK1544","LU1366334651.USD","03986","03296","BK1592","BK1507","LU0082770016.USD","BK1191","LU0307460666.USD","SG9999011746.SGD","IE00B5MMRT66.SGD","BK1526","LU0315179316.USD","LU0128522157.USD","HK0001040143.USD","LU2476274308.USD","LU0029875118.USD","BK1523","LU0823426308.USD","LU1282649067.USD","IE00BGHQDM52.EUR","LU2264538146.SGD","LU0359201885.HKD","LU0359201612.USD","LU0140636845.USD","LU0165289439.USD","BK1116","LU0096374516.USD","LU1769817096.USD","02359","LU0067412154.USD","LU0164865239.USD","LU1481107354.HKD","IE00BPRC5H50.USD","LU0214875030.USD","BK1610","BK1198","LU2097828631.EUR","BK1163","LU2294711473.HKD","LU1242518857.USD","LU1064131342.USD","LU1282648689.USD","LU0164939612.USD","LU1226287529.USD","LU2778985437.USD","LU1769817179.HKD","01108","BK1197","LU1152091168.USD","LU1813983027.USD","LU0348735423.USD","HK0000352291.HKD","LU0359202008.SGD","LU1719994722.HKD","02465","BK1144","LU0531970944.HKD","LU0417516902.SGD","BK1503","BK1562","LU0348767384.USD","HK0000352382.USD","LU0348805143.USD","02218","LU0082770016.SGD","06869","LU1993786604.SGD","BK1154","LU0348816934.USD","SG9999002463.SGD","HK0000252160.HKD","IE0031814852.USD","LU0791590937.USD","LU0329678337.USD","LU0229945570.USD","LU2008162690.USD","LU0061477393.USD","LU1808992512.USD","LU0328353924.USD","LU1105468828.SGD","LU0708995583.HKD","03661","01349","03328","BK1506","02691","LU0181495838.USD","LU0890818403.SGD","BK1521","IE00B543WZ88.USD","BK1171","SG9999002828.SGD","BK1554","LU0797268264.HKD","LU1048596156.SGD","LU0348825331.USD","LU0326950275.SGD","03200","LU1988902786.USD","LU1328277881.USD","LU0862451753.SGD","BK1223","LU1244550221.USD","SG9999001093.SGD","LU0516423091.SGD","LU1504937902.USD","LU0329678170.USD","IE0008368742.USD","03750","BK1183","LU0737861772.HKD","LU0072913022.USD","LU0918141705.HKD","01033","LU0348814723.USD","01276","HK0000306701.USD","BK1205","LU0254981946.USD","LU0211977185.USD","BK1594","LU0607220059.USD","LU2476274720.SGD","LU0516423174.USD","EWH","LU0634319403.HKD","LU0384037296.USD","03968","LU1244550494.USD","IE0032431581.USD","BK1147","LU0051755006.USD","LU1008478684.HKD","LU0106252389.USD","LU0163747925.USD","BK1514","LU0543330483.HKD","01057","LU0456846285.SGD","LU0320764755.SGD","IE00B29SXG58.USD","LU1961090484.USD","LU2097828714.EUR","LU0588546209.SGD","BK1564","LU0456854461.SGD","LU1794554557.SGD","BK1193","LU1115378108.SGD","LU0054450605.USD","HK0000306685.HKD","02607","LU0117841782.USD","BK1166","LU1251922891.USD","LU3063872942.SGD","LU0345780521.USD","LU0880133367.SGD","IE00BF5LJ272.USD","LU1152091754.HKD","LU1046422090.SGD","IE00B031HY20.USD","06031","LU0049853897.USD","LU2399975544.HKD","LU0737861699.HKD","BK1522","LU2242644610.SGD","LU0106959298.USD","03678","HK0000252152.HKD","LU0488056044.USD","LU0868486357.SGD","LU1770034418.SGD","LU1211504680.USD","IE00BZ08YT58.USD","BK1231","LU0823426480.USD","SG9999014674.SGD","LU0266512473.USD","BK1105","LU0456827905.SGD","06066","LU2226246903.HKD","SG9999001226.SGD","BK1505","BK1560","BK1551","LU0886674414.USD","00042","LU1303224171.USD","LU1880383440.USD","LU1688375341.USD","HK0000320223.HKD","LU0593848301.USD","LU1023057109.AUD","BK1240","399300","00187","HK0000320264.USD","LU2097828557.USD","LU0228659784.USD","IE0034224299.USD","LU0828237940.HKD","BK1237","BK1513","LU0502904849.HKD","LU0348827113.USD","LU0173614495.USD","LU0455707207.USD","01812","LU0531971595.HKD","LU1960683339.HKD","LU0048580855.USD","LU0821914370.USD","159982","LU0469268626.HKD","00553","LU0231483743.USD","00956","03143","LU0648948544.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646336393","title":"Hengrui Pharma Gets Nod to Trial HRS-4508 Tablets As Advanced Tumor Treatment; Shares Down 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646336393","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646336393?lang=en_us&edition=fundamental","pubTime":"2026-06-26 11:10","pubTimestamp":1782443414,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  received approval from China's National Medical Products Administration to conduct clinical trials on HRS-4508 tablets, according to a Shanghai bourse filing on Friday.The drug will be tested as a treatment for advanced solid tumors.The pharmaceutical company invested 81.8 million yuan into the research and development of the drug.The company's Hong Kong shares dropped 4%, while Shanghai shares slipped 1% during the morning trade.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0239","01276","IE0031619046.USD","600276","LU2580892789.USD","BK0012","IE00B66KJ199.SGD","LU1781817850.SGD","LU0359202008.SGD","IE00B7SZL793.SGD","LU1064131003.USD","LU1997245094.SGD","LU2097828631.EUR","LU0405327148.USD","LU2097828805.USD","LU2148510915.USD","LU1997244956.HKD","LU2328871848.SGD","LU1255011170.USD","LU1815336091.USD","BK4157","LU1969619763.USD","LU1328615791.USD","LU2488822045.USD","LU1580142542.USD","LU2543165471.USD","LU0757428866.USD","BK0196","LU1023057109.AUD","IE00B19Z4B17.USD","LU0359201885.HKD","BK0060","LU2097828714.EUR","BK0183","LU0359201612.USD","LU1655091616.SGD","BK1191","BK0188","AEIS","LU1997245177.USD","LU2097828557.USD","LU0405327494.USD","LU1146622755.USD","LU1820825898.SGD","LU2097828474.EUR","LU2580892862.HKD","BK0028","LU2495084118.USD","LU1064130708.USD","LU2289578879.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646338034","title":"Hengrui Pharmaceuticals Unit Wins China Approval to Expand Indication of Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2646338034","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646338034?lang=en_us&edition=fundamental","pubTime":"2026-06-26 10:51","pubTimestamp":1782442263,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  said a unit received China's National Medical Products Administration approval to expand the indication of adebrelimab, according to a Thursday Hong Kong bourse filing.The drug can now be used as neoadjuvant therapy in non-small cell lung cancer. It was previously approved as a first-line treatment of extensive-stage small cell lung cancer.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0359201612.USD","BK1191","01276","LU0359201885.HKD","LU0359202008.SGD","LU2543165471.USD","LU1023057109.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184216560","title":"Movement Alert｜Hengrui Pharmaceuticals Falls 3.53% in Regular Trading, Trading at 54.15 HKD","url":"https://stock-news.laohu8.com/highlight/detail?id=1184216560","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184216560?lang=en_us&edition=fundamental","pubTime":"2026-06-26 10:15","pubTimestamp":1782440114,"startTime":"0","endTime":"0","summary":"On June 26, Hengrui Pharmaceuticals fell 3.53% in regular trading, trading at 54.15 HKD/share, with turnover of 116 million HKD.Within the Pharmaceuticals sector where Hengrui Pharmaceuticals...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646380010","title":"Hengrui Pharmaceuticals Unit Wins China Marketing Approval for Dry Eye Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2646380010","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646380010?lang=en_us&edition=fundamental","pubTime":"2026-06-26 10:06","pubTimestamp":1782439585,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals  said a unit received marketing approval from China's National Medical Products Administration for Cyclosporine Ophthalmic Solution , marketed as CyclASol, according to a Thursday Hong Kong bourse filing.CyclASol is indicated to promote tear secretion and improve the signs and symptoms of dry eye disease in patients with reduced tear production.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0359202008.SGD","01276","BK1191","LU2543165471.USD","LU0359201885.HKD","LU0359201612.USD","LU1023057109.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141236799","title":"Hengrui Pharma Secures NMPA Approval for Adebrelimab as China’s First Domestic Peri-operative PD-L1 Therapy for Resectable NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1141236799","media":"Bulletin Express","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141236799?lang=en_us&edition=fundamental","pubTime":"2026-06-25 21:04","pubTimestamp":1782392687,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma, 01276.HK) announced that its wholly owned subsidiary, Shanghai Suncadia Medicine Co., Ltd., has received National Medical Products...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116136614","title":"Hengrui Pharma secures NMPA green light for China’s first 0.1% water-free cyclosporine eye-drop","url":"https://stock-news.laohu8.com/highlight/detail?id=1116136614","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116136614?lang=en_us&edition=fundamental","pubTime":"2026-06-25 21:04","pubTimestamp":1782392677,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) announced that its subsidiary Chengdu Suncadia Medicine has received National Medical Products Administration (NMPA) approval to launch...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137621027","title":"Hengrui Pharma's Adebrelimab Injection Gains Approval for Additional NSCLC Perioperative Indication","url":"https://stock-news.laohu8.com/highlight/detail?id=1137621027","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137621027?lang=en_us&edition=fundamental","pubTime":"2026-06-25 20:59","pubTimestamp":1782392348,"startTime":"0","endTime":"0","summary":"Hengrui Pharma has announced that its subsidiary, Shanghai Shengdi Pharmaceutical Co., Ltd., recently received notification from the National Medical Products Administration. The notification...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU2488822045.USD","BK0060","BK0183","LU2097828631.EUR","LU2328871848.SGD","LU2580892789.USD","600276","LU0359201885.HKD","LU0405327494.USD","BK1191","LU1997245094.SGD","BK0012","LU1997244956.HKD","LU1064131003.USD","LU1820825898.SGD","LU2097828714.EUR","LU2495084118.USD","BK0028","LU1146622755.USD","LU2097828805.USD","LU2148510915.USD","LU0359201612.USD","01276","LU1023057109.AUD","LU1328615791.USD","LU1580142542.USD","LU2580892862.HKD","BK0188","LU0405327148.USD","LU1781817850.SGD","LU1655091616.SGD","LU1064130708.USD","BK0196","LU2289578879.USD","LU1969619763.USD","LU1255011170.USD","LU2097828474.EUR","LU1997245177.USD","LU2543165471.USD","LU0359202008.SGD","LU2097828557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646082968","title":"Jiangsu Hengrui Pharmaceuticals - Subsidiary Received Notification from Nmpa Approving New Indication for Adebrelimab Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2646082968","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646082968?lang=en_us&edition=fundamental","pubTime":"2026-06-25 20:48","pubTimestamp":1782391701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260625:nFWN42W15H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0196","LU2543165471.USD","BK0188","LU1255011170.USD","LU1820825898.SGD","LU2097828557.USD","LU2148510915.USD","BK0183","LU2580892789.USD","600276","LU2580892862.HKD","LU1064131003.USD","LU2328871848.SGD","BK0028","LU0359201885.HKD","LU2488822045.USD","LU2097828805.USD","BK0060","LU1064130708.USD","LU2495084118.USD","LU1023057109.AUD","LU1328615791.USD","LU1580142542.USD","LU1781817850.SGD","LU1997244956.HKD","BK0012","LU1997245177.USD","BK1191","LU1146622755.USD","LU2289578879.USD","LU1655091616.SGD","LU1997245094.SGD","LU2097828474.EUR","LU0359202008.SGD","LU0405327148.USD","01276","BK0239","LU2097828631.EUR","LU1969619763.USD","LU0405327494.USD","LU2097828714.EUR","LU0359201612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162114379","title":"AH Share Premium and Deviation Rankings as of June 24th Close","url":"https://stock-news.laohu8.com/highlight/detail?id=1162114379","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162114379?lang=en_us&edition=fundamental","pubTime":"2026-06-24 16:24","pubTimestamp":1782289475,"startTime":"0","endTime":"0","summary":"As of the market close on June 24th, the top three stocks with the highest AH share premiums were NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and SINOPEC SSC (01033), with premiums of 881.82%,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0327786744.USD","BK1537","LU0043850808.USD","LU0181495838.USD","BK1523","LU1880383440.USD","LU0048580855.USD","BK1510","BK1198","LU1282649810.SGD","BK1594","LU0890818403.SGD","LU0502904849.HKD","BK1546","LU0791591158.USD","BK1544","BK1564","LU0163747925.USD","LU2097828805.USD","LU1794554557.SGD","LU0328353924.USD","LU2476274720.SGD","LU0823426480.USD","LU0593848301.USD","LU1504937902.USD","LU1242518857.USD","LU0128522157.USD","BK1583","LU0348788117.USD","02359","LU2279858448.HKD","LU0516422366.SGD","BK1562","LU2097828557.USD","02899","BK1197","LU0828237940.HKD","LU1481107354.HKD","LU1675838814.USD","03200","LU2097828474.EUR","BK1116","IE00BF5LJ272.USD","LU0516423091.SGD","06613","IE00B543WZ88.USD","LU2045819591.USD","00553","00916","LU0531970944.HKD","LU1960683339.HKD","LU0572944931.SGD","IE00B5MMRT66.SGD","LU0307460666.USD","SG9999001093.SGD","LU0140636845.USD","LU2008162690.USD","BK1604","LU0634319403.HKD","HK0000252152.HKD","IE00BVYPNP33.GBP","LU1880383366.USD","LU0165289439.USD","LU0164880469.USD","LU0049853897.USD","LU1282648689.USD","LU2177674079.SGD","LU0918141887.USD","BK1530","LU1688375341.USD","LU0588546209.SGD","LU0370786039.SGD","LU1993786604.SGD","02208","BK1576","LU2097828631.EUR","LU0117841782.USD","LU0868486357.SGD","LU1303224171.USD","LU0886674414.USD","01088","LU0029875118.USD","IE0008368742.USD","LU0672654166.SGD","LU0254981946.USD","LU0054450605.USD","LU0329678337.USD","LU0862451753.SGD","LU0880133367.SGD","LU1808992512.USD","LU1366334651.USD","06869","LU0348816934.USD","BK1171","LU1961090484.USD","LU0823426308.USD","LU0607220059.USD","LU0449515922.USD","01033","HK0000500386.USD","IE0008369823.USD","LU0348805143.USD","01108","BK1144","LU0287142896.SGD","LU0345780521.USD","HK0000252160.HKD","LU1023057109.AUD","LU0082770016.USD","01812","BK1205","03328","LU2097828714.EUR","LU0164865239.USD","02476","LU0039217434.USD","LU0051755006.USD","LU1328277881.USD","BK1538","LU0359202008.SGD","LU0455707207.USD","01898","LU1769817179.HKD","SG9999004220.SGD","LU0348766576.USD","LU2039709279.SGD","IE0034224299.USD","03678","HK0001040168.HKD","BK1526","LU1251922891.USD","LU0329678170.USD","BK1105","02218","LU0648948544.HKD","LU0516422440.USD","00956","HK0000306685.HKD","BK1506","BK1149","IE0032431581.USD","LU1152091168.USD","IE00BZ08YT58.USD","BK1223","BK1592","LU0737861699.HKD","LU0320764755.SGD","BK1125","LU3063872942.SGD","01276","IE00B031J352.USD","LU0315179316.USD","LU0417516902.SGD","LU1769817096.USD","HK0000320223.HKD","BK1141","LU0543330566.HKD","LU0708995583.HKD","LU2294711473.HKD","399300","LU0979878070.USD","LU0797268264.HKD","BK1237","01057","LU0228367735.SGD","IE00B031HY20.USD","LU0214875030.USD","IE00BVYPNQ40.USD","LU0326950275.SGD","LU0229945570.USD","03968","SG9999001226.SGD","HK0001040143.USD","LU0456854461.SGD","SG9999011746.SGD","IE00BGHQDM52.EUR","IE00BGV7N243.SGD","LU1224709979.USD","LU1282649141.HKD","LU1244550494.USD","HK0000320264.USD","LU1770034418.SGD","LU0231483743.USD","BK1610","LU0620787316.HKD","BK1560","LU0561508036.HKD","BK1578","03143","LU0589944569.HKD","LU1807302812.USD","00168","LU0456827905.SGD","LU0067412154.USD","LU1720050803.USD","LU1171460220.USD","LU0149534421.HKD","SG9999002463.SGD","LU1244550221.USD","BK1140","BK1166","03986","LU0456846285.SGD","LU1046422090.SGD","LU1105468828.SGD","LU0072913022.USD","LU0359201612.USD","159982","LU0531971595.HKD","02691","LU2399975544.HKD","BK1147","BK1170","LU0061477393.USD","LU2226246903.HKD","LU0149721374.USD","LU1831875114.USD","BK1503","IE00B3M56506.USD","LU0314109678.HKD","BK1507","00719","00991","LU0543330483.HKD","BK1193","IE00B29SXG58.USD","LU2543165471.USD","BK1505","LU1719994722.HKD","HK0000352291.HKD","LU0082770016.SGD","LU1008478684.HKD","00042","IE00BYV24P56.USD","SG9999002828.SGD","LU1048596156.SGD","LU2778985437.USD","BK1521","BK1513","LU1282649067.USD","02465","LU0164939612.USD","LU0052750758.USD","LU0823040885.USD","IE00BZ08YS42.EUR","LU0211977185.USD","LU0431992006.USD","LU0501845795.SGD","LU0384037296.USD","LU0540923850.HKD","LU0737861772.HKD","00588","LU0828237510.HKD","BK1110","LU0918141705.HKD","LU0640798160.USD","LU2242644610.SGD","LU0173614495.USD","IE00BMCWC346.EUR","LU0348767384.USD","LU0266512127.USD","LU0821914370.USD","LU0106959298.USD","LU2125910500.SGD","BK1558","LU1244550577.SGD","BK1240","LU1242518931.SGD","BK1178","LU0348827113.USD","01330","LU0449509016.USD","EWH","HK0000306701.USD","LU0228659784.USD","LU2264538146.SGD","LU1988902786.USD","LU0348735423.USD","03750","LU0348814723.USD","LU1366334578.USD","LU0348825331.USD","02607","LU0359201885.HKD","01081","LU1064131342.USD","BK1515","LU0320764599.SGD","SG9999014674.SGD","LU0244354667.USD","IE00BZ08YR35.GBP","LU0106252389.USD","BK1180","BK1231","LU0516423174.USD","LU1188198961.HKD","BK1202","LU1226287529.USD","LU0345780281.USD","SG9999006597.SGD","LU1115378108.SGD","IE0031814852.USD","BK1154","LU1211504680.USD","LU1813983027.USD","BK1191","LU0871576103.HKD","LU0096374516.USD","LU0488056044.USD","LU0516422952.EUR","LU0469268626.HKD","LU0266512473.USD","LU1152091754.HKD","LU0791590937.USD","02338","HK0000352382.USD","BK1522","BK1551","LU2476274308.USD","BK1554","BK1514","LU0463099449.HKD","BK1163","03296","BK1183","LU0417516738.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192624255","title":"Movement Alert｜Hengrui Medicine Rises 3.47% in Regular Trading, First Self-Developed Innovative Drug Marketing Application Accepted by EMA","url":"https://stock-news.laohu8.com/highlight/detail?id=1192624255","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192624255?lang=en_us&edition=fundamental","pubTime":"2026-06-24 09:44","pubTimestamp":1782265476,"startTime":"0","endTime":"0","summary":"On June 24, Hengrui Medicine (01276.HK) rose 3.47% in regular trading, trading at HK$57.9/share, with turnover of HK$26.10 million. The stock continued its upward momentum following a 3.73% gain in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114089161","title":"Hengrui Pharma Withdraws Registration Application for Emaxitinib Ointment","url":"https://stock-news.laohu8.com/highlight/detail?id=1114089161","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114089161?lang=en_us&edition=fundamental","pubTime":"2026-06-23 19:34","pubTimestamp":1782214475,"startTime":"0","endTime":"0","summary":"Hengrui Pharma (ASX: 01276) has announced that it recently received a \"Notice of Termination of Drug Registration Application\" from the National Medical Products Administration (NMPA), agreeing to...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828631.EUR","01276","BK0239","LU1023057109.AUD","LU2097828557.USD","LU2580892789.USD","LU2328871848.SGD","LU1064131003.USD","BK0188","LU0359202008.SGD","BK0028","LU1820825898.SGD","LU1655091616.SGD","LU0359201612.USD","LU2148510915.USD","LU2580892862.HKD","LU0405327148.USD","BK1191","LU2495084118.USD","BK0060","LU2097828714.EUR","LU0359201885.HKD","LU2488822045.USD","LU1064130708.USD","LU1146622755.USD","BK0196","LU2543165471.USD","LU1781817850.SGD","600276","LU2097828805.USD","BK0012","LU1997245094.SGD","LU1997245177.USD","LU2097828474.EUR","BK0183","LU1969619763.USD","LU1255011170.USD","LU1580142542.USD","LU1997244956.HKD","LU2289578879.USD","LU1328615791.USD","LU0405327494.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100407015","title":"Hong Kong Stocks Surge: Innovative Drug Sector Rallies on Regulatory Report and New Foreign Investment Policies","url":"https://stock-news.laohu8.com/highlight/detail?id=1100407015","media":"Stock News","labels":["policyRegulatory","economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100407015?lang=en_us&edition=fundamental","pubTime":"2026-06-23 11:46","pubTimestamp":1782186399,"startTime":"0","endTime":"0","summary":"Shares in the innovative drug sector experienced a broad-based rally today.At the time of writing, SSY GROUP (02005) was up 6.93% at HK$2.16, KEYMED BIO-B (02162) gained 4.14% to HK$59.05, HENGRUI...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory,economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1794554557.SGD","LU0634319403.HKD","LU2097828557.USD","LU0348767384.USD","LU2476274308.USD","LU2488822045.USD","HK0000165453.HKD","LU0417516738.SGD","LU0561508036.HKD","LU2097828474.EUR","LU2543165471.USD","LU0417516902.SGD","LU0348784397.USD","01276","LU2097828631.EUR","LU0502904849.HKD","LU2328871848.SGD","BK4588","BK1161","LU1961090484.USD","LU0359202008.SGD","LU2242644610.SGD","BK1589","LU0348766576.USD","LU2097828805.USD","BK1587","LU0540923850.HKD","09926","LU2778985437.USD","BK1515","LU2460026573.USD","LU2399975544.HKD","LU0359201885.HKD","IE00B543WZ88.USD","09939","LU0359201612.USD","159992","IE00BPRC5H50.USD","02162","LU1720050803.USD","LU0348735423.USD","01801","LU1023057109.AUD","LU0348783233.USD","BK4585","LU0348825331.USD","IE00B5MMRT66.SGD","LU0455707207.USD","BK1574","06978","BK1583","LU2097828714.EUR","LU1969619763.USD","LU0348827113.USD","BK1191","LU0417516571.SGD","LU2476274720.SGD","159938","02005","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645004981","title":"European Drug Regulator Accepts Hengrui Pharma's Marketing Application for Revulutamide Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2645004981","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645004981?lang=en_us&edition=fundamental","pubTime":"2026-06-23 10:40","pubTimestamp":1782182438,"startTime":"0","endTime":"0","summary":"The European Medicines Agency accepted Jiangsu Hengrui Pharmaceuticals'  marketing application for revulutamide tablets, according to a Shanghai bourse filing on Tuesday.The drug is used in combination with androgen deprivation therapy for the treatment of adult male patients with prostate cancer.The Chinese pharmaceutical company's shares rose 2% during the morning trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1023057109.AUD","01276","EPV","LU2543165471.USD","LU0359201612.USD","LU0359202008.SGD","BK1191","LU0359201885.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196099833","title":"Movement Alert｜Hengrui Medicine Rises 3.73% in Regular Trading, First Self-Developed Innovative Drug Marketing Application Accepted by EMA","url":"https://stock-news.laohu8.com/highlight/detail?id=1196099833","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196099833?lang=en_us&edition=fundamental","pubTime":"2026-06-23 09:37","pubTimestamp":1782178654,"startTime":"0","endTime":"0","summary":"On June 23, Hengrui Medicine rose 3.73% in regular trading, trading at 57.45 HKD/share, with turnover of approximately 42.72 million HKD.On the news front, the company announced on June 22 that the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191996353","title":"Hengrui Pharma's Novel Drug Application for Rezvilutamide Accepted by European Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1191996353","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191996353?lang=en_us&edition=fundamental","pubTime":"2026-06-22 16:48","pubTimestamp":1782118137,"startTime":"0","endTime":"0","summary":"An application for marketing authorization of a new drug developed by Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (ASX: 600276) has been formally accepted for review by the European Medicines Agency...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2328871848.SGD","BK1191","LU1820825898.SGD","BK0012","LU2097828805.USD","LU1023057109.AUD","LU1064131003.USD","LU1997244956.HKD","LU1655091616.SGD","LU1997245094.SGD","LU0405327494.USD","LU1255011170.USD","LU2148510915.USD","LU2097828714.EUR","BK0239","LU0359201885.HKD","BK0188","LU1781817850.SGD","01276","LU0359201612.USD","LU1064130708.USD","BK0060","LU2097828474.EUR","LU2495084118.USD","LU1997245177.USD","LU2543165471.USD","LU2289578879.USD","LU2580892862.HKD","EMA","BK0183","BK4081","BK0196","LU0405327148.USD","LU0359202008.SGD","LU2097828557.USD","600276","LU2488822045.USD","LU1969619763.USD","LU2580892789.USD","LU1580142542.USD","IPOS","LU2097828631.EUR","BK0028","LU1328615791.USD","LU1146622755.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170586697","title":"AH Premium and Deviation Data for June 22","url":"https://stock-news.laohu8.com/highlight/detail?id=1170586697","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170586697?lang=en_us&edition=fundamental","pubTime":"2026-06-22 16:25","pubTimestamp":1782116720,"startTime":"0","endTime":"0","summary":"Data for the close on June 22 reveals the leading and lagging stocks in terms of AH share premium rates.The three stocks with the highest AH premium rates were NE ELECTRIC (HKG: 00042), ZHEJIANG...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2045819591.USD","IE00B5MMRT66.SGD","LU0431992006.USD","BK1560","LU2476274720.SGD","HK0001040168.HKD","LU1224709979.USD","LU1807302812.USD","IE00BPRC5H50.USD","LU1831875114.USD","02768","00042","BK1171","BK1166","LU0320764599.SGD","LU0918141887.USD","LU0501845795.SGD","LU0516422952.EUR","LU0359201885.HKD","LU2226246903.HKD","01057","LU0228367735.SGD","LU0315179316.USD","00991","IE00BZ08YR35.GBP","LU0163747925.USD","LU1226287529.USD","LU2399975544.HKD","LU0149721374.USD","00895","LU1880383366.USD","LU1211504680.USD","LU1105468828.SGD","LU0797268264.HKD","01349","02476","LU1046422090.SGD","SG9999006597.SGD","IE00BZ08YT58.USD","SG9999001226.SGD","03986","HK0001040143.USD","LU0314109678.HKD","LU1242518931.SGD","LU0384037296.USD","LU0449515922.USD","LU0417516902.SGD","LU0572944931.SGD","BK1501","HK0000252160.HKD","LU0463099449.HKD","LU1328277881.USD","LU0117841782.USD","IE00B031HY20.USD","02359","BK1110","LU1244550221.USD","LU0540923850.HKD","LU0327786744.USD","LU0307460666.USD","LU0588546209.SGD","LU0737861699.HKD","LU1115378108.SGD","LU0543330483.HKD","LU1251922891.USD","LU0918141705.HKD","399300","BK1583","BK1594","BK1229","IE00B3M56506.USD","LU0348825331.USD","BK1223","SG9999002463.SGD","HK0000252152.HKD","159982","IE00B29SXG58.USD","LU0979878070.USD","LU0214875030.USD","BK1202","LU0149534421.HKD","LU0593848301.USD","IE00BVYPNP33.GBP","LU0106959298.USD","LU1770034418.SGD","LU0229945570.USD","02208","BK1551","LU0862451753.SGD","LU0320764755.SGD","LU0348805143.USD","LU0531970944.HKD","LU1303224171.USD","LU0048580855.USD","LU1282649810.SGD","01033","LU0359202008.SGD","LU0455707207.USD","LU0456846285.SGD","LU1675838814.USD","LU1244550577.SGD","BK1576","LU1023057109.AUD","BK1170","IE00BYV24P56.USD","BK1154","BK1191","01528","BK1205","BK1558","HK0000500386.USD","LU0231483743.USD","BK1507","BK1546","02338","LU1813983027.USD","SG9999014674.SGD","BK1563","03750","03296","BK1140","LU1961090484.USD","BK1237","BK1105","LU2125910500.SGD","LU0244354667.USD","03143","BK1526","LU0348827113.USD","LU0890818403.SGD","LU0868486357.SGD","IE00BZ08YS42.EUR","LU0072913022.USD","LU0561508036.HKD","LU0348767384.USD","LU0589944569.HKD","LU1188198961.HKD","BK1185","SG9999011746.SGD","06613","IE0031814852.USD","LU2294711473.HKD","SG9999004220.SGD","LU1244550494.USD","LU0880133367.SGD","03268","LU0672654166.SGD","EWH","BK1125","LU2543165471.USD","IE00B031J352.USD","LU0417516738.SGD","LU0708995583.HKD","LU0607220059.USD","LU1808992512.USD","BK1530","BK1567","LU1993786604.SGD","LU0128522157.USD","BK1610","LU2039709279.SGD","03328","SG9999002828.SGD","HK0000352382.USD","LU0488056044.USD","LU1366334578.USD","00956","02691","LU0348814723.USD","LU2778985437.USD","BK1522","LU0634319403.HKD","LU0502904849.HKD","00995","LU0516423091.SGD","BK1144","IE00BMCWC346.EUR","LU0456827905.SGD","LU1720050803.USD","LU0051755006.USD","BK1514","00916","HK0000352291.HKD","LU0348788117.USD","LU1366334651.USD","IE00BF5LJ272.USD","BK1552","LU1282649067.USD","01330","IE0008368742.USD","BK1163","BK1193","LU0640798160.USD","LU0823426480.USD","BK1141","BK1116","BK1258","BK1149","BK1503","LU0164880469.USD","LU0348766576.USD","LU0823040885.USD","LU1880383440.USD","BK1554","IE00BGHQDM52.EUR","IE00BVYPNQ40.USD","LU0359201612.USD","LU0370786039.SGD","LU0516422366.SGD","LU0254981946.USD","LU0648948544.HKD","LU1688375341.USD","LU2242644610.SGD","02009","03968","BK1231","BK1240","LU0348816934.USD","LU0287142896.SGD","01108","LU0791590937.USD","LU0791591158.USD","LU0516422440.USD","BK1521","BK1564","LU0516423174.USD","LU0823426308.USD","LU1960683339.HKD","01812","06031","LU1008478684.HKD","SG9999001093.SGD","LU0052750758.USD","IE00B543WZ88.USD","LU0326950275.SGD","01276","02218","IE0008369823.USD","LU0348735423.USD","BK1562","LU0029875118.USD","LU0067412154.USD","LU0173614495.USD","LU1242518857.USD","01072","LU1481107354.HKD","LU0469268626.HKD","BK1135","LU0054450605.USD","IE0034224299.USD","LU0449509016.USD","LU1152091754.HKD","01081","LU1282648689.USD","BK1537","LU1282649141.HKD","LU2476274308.USD","03678","LU0543330566.HKD","BK1147","LU1152091168.USD","00588","LU1794554557.SGD","LU1719994722.HKD","BK1513"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135717515","title":"Movement Alert｜Hengrui Medicine Falls 3.02% in Regular Trading, Broad Pharma Sector Sell-Off Amid Geopolitical Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=1135717515","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135717515?lang=en_us&edition=fundamental","pubTime":"2026-06-22 10:30","pubTimestamp":1782095402,"startTime":"0","endTime":"0","summary":"On June 22, Hengrui Medicine (01276.HK) declined 3.02% in regular trading, trading at HK$52.95/share, with turnover of HK$66.36 million. The decline came amid a broad sell-off across the Hong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}